Brevan Howard Capital Management LP Castle Biosciences Inc Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 19,128 shares of CSTL stock, worth $639,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,128
Previous 41,301
53.69%
Holding current value
$639,831
Previous $843,000
48.4%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CSTL
# of Institutions
185Shares Held
27MCall Options Held
42.2KPut Options Held
9.3K-
Black Rock Inc. New York, NY3.04MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$72.7 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.79MShares$60 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.52MShares$50.7 Million2.16% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.47MShares$49.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $880M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...